In profoundly immunocompromised patients, moulds can enter the bloodstream, leading to systemic fungal infection or sepsis. Clinical manifestations include fever, hypotension, multi-organ dysfunction, and shock. Treatment necessitates intravenous antifungal agents, supportive therapy, and urgent remediation of the environmental source if applicable.
